Innovations May 2025

Shaping the Future of HIV Research

In the amfAR Interview, virologist Dr. Melanie Ott discusses advances in HIV cure science, emerging technologies like AI, and why funding matters.

Unprecedented Cuts Across Health and Human Services Put Lives in Peril

amfAR urges the Administration to sustain critical investments in the agencies that are central to our national HIV response.

Helping Youth Transition into Adult Care

A new study examines the medical and psychosocial needs of young people who have lived with HIV their entire lives.

Researchers Announce Two New Probable HIV Cure Cases

If confirmed, the Chicago and Oslo Patients would bring the total number of cures to 10.


CEO Kevin Robert Frost has announced he will retire at the end of the year, handing the reins to Chief Development Officer Kyle Clifford.

Kyle Clifford maps out his vision as he steps into the leadership role.

Dr. Andrea Gramatica, Karen Mateo, and Shawn Davidson join amfAR.

amfAR CEO Kevin Robert Frost introduces the new issue of Innovations.

A kind, adventurous woman who loved many causes, Dorothea Lyman extended her long support of amfAR with a legacy gift upon her passing.

amfAR argues that robust federal investment in biomedical research is essential both for protecting health and securing our economic future.

Learning from Post-Treatment Control

Groundbreaking amfAR immunotherapy trial yields new knowledge, new research.

New research aims to expand prevention and improve health outcome for women in Indonesia.